These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 17662526)

  • 1. Regulation of central nervous system cholesterol homeostasis by the liver X receptor agonist TO-901317.
    Eckert GP; Vardanian L; Rebeck GW; Burns MP
    Neurosci Lett; 2007 Aug; 423(1):47-52. PubMed ID: 17662526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver X receptor stimulates cholesterol efflux and inhibits expression of proinflammatory mediators in human airway smooth muscle cells.
    Delvecchio CJ; Bilan P; Radford K; Stephen J; Trigatti BL; Cox G; Parameswaran K; Capone JP
    Mol Endocrinol; 2007 Jun; 21(6):1324-34. PubMed ID: 17405904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pitavastatin effect on ATP binding cassette A1-mediated lipid efflux from macrophages: evidence for liver X receptor (LXR)-dependent and LXR-independent mechanisms of activation by cAMP.
    Zanotti I; Potì F; Favari E; Steffensen KR; Gustafsson JA; Bernini F
    J Pharmacol Exp Ther; 2006 Apr; 317(1):395-401. PubMed ID: 16415093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidized LDL upregulated ATP binding cassette transporter-1 in THP-1 macrophages.
    Tang CK; Yi GH; Yang JH; Liu LS; Wang Z; Ruan CG; Yang YZ
    Acta Pharmacol Sin; 2004 May; 25(5):581-6. PubMed ID: 15132822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different roles of liver X receptor alpha and beta in lipid metabolism: effects of an alpha-selective and a dual agonist in mice deficient in each subtype.
    Lund EG; Peterson LB; Adams AD; Lam MH; Burton CA; Chin J; Guo Q; Huang S; Latham M; Lopez JC; Menke JG; Milot DP; Mitnaul LJ; Rex-Rabe SE; Rosa RL; Tian JY; Wright SD; Sparrow CP
    Biochem Pharmacol; 2006 Feb; 71(4):453-63. PubMed ID: 16325781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery and implementation of transcriptional biomarkers of synthetic LXR agonists in peripheral blood cells.
    DiBlasio-Smith EA; Arai M; Quinet EM; Evans MJ; Kornaga T; Basso MD; Chen L; Feingold I; Halpern AR; Liu QY; Nambi P; Savio D; Wang S; Mounts WM; Isler JA; Slager AM; Burczynski ME; Dorner AJ; LaVallie ER
    J Transl Med; 2008 Oct; 6():59. PubMed ID: 18925943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholesterol independent effect of LXR agonist TO-901317 on gamma-secretase.
    Czech C; Burns MP; Vardanian L; Augustin A; Jacobsen H; Baumann K; Rebeck GW
    J Neurochem; 2007 May; 101(4):929-36. PubMed ID: 17472585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atorvastatin inhibits ABCA1 expression and cholesterol efflux in THP-1 macrophages by an LXR-dependent pathway.
    Qiu G; Hill JS
    J Cardiovasc Pharmacol; 2008 Apr; 51(4):388-95. PubMed ID: 18427282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of intestinal ATP-binding cassette transporters by a phytosterol-derived liver X receptor agonist.
    Kaneko E; Matsuda M; Yamada Y; Tachibana Y; Shimomura I; Makishima M
    J Biol Chem; 2003 Sep; 278(38):36091-8. PubMed ID: 12847102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel liver X receptor agonist establishes species differences in the regulation of cholesterol 7alpha-hydroxylase (CYP7a).
    Menke JG; Macnaul KL; Hayes NS; Baffic J; Chao YS; Elbrecht A; Kelly LJ; Lam MH; Schmidt A; Sahoo S; Wang J; Wright SD; Xin P; Zhou G; Moller DE; Sparrow CP
    Endocrinology; 2002 Jul; 143(7):2548-58. PubMed ID: 12072387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SREBP-2 positively regulates transcription of the cholesterol efflux gene, ABCA1, by generating oxysterol ligands for LXR.
    Wong J; Quinn CM; Brown AJ
    Biochem J; 2006 Dec; 400(3):485-91. PubMed ID: 16901265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OSBP negatively regulates ABCA1 protein stability.
    Bowden K; Ridgway ND
    J Biol Chem; 2008 Jun; 283(26):18210-7. PubMed ID: 18450749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological activation of liver X receptors promotes reverse cholesterol transport in vivo.
    Naik SU; Wang X; Da Silva JS; Jaye M; Macphee CH; Reilly MP; Billheimer JT; Rothblat GH; Rader DJ
    Circulation; 2006 Jan; 113(1):90-7. PubMed ID: 16365197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 24(S)-hydroxycholesterol participates in a liver X receptor-controlled pathway in astrocytes that regulates apolipoprotein E-mediated cholesterol efflux.
    Abildayeva K; Jansen PJ; Hirsch-Reinshagen V; Bloks VW; Bakker AH; Ramaekers FC; de Vente J; Groen AK; Wellington CL; Kuipers F; Mulder M
    J Biol Chem; 2006 May; 281(18):12799-808. PubMed ID: 16524875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of cholesterol homeostasis by the liver X receptors in the central nervous system.
    Whitney KD; Watson MA; Collins JL; Benson WG; Stone TM; Numerick MJ; Tippin TK; Wilson JG; Winegar DA; Kliewer SA
    Mol Endocrinol; 2002 Jun; 16(6):1378-85. PubMed ID: 12040022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucocorticoid receptor regulates ATP-binding cassette transporter-A1 expression and apolipoprotein-mediated cholesterol efflux from macrophages.
    Ayaori M; Sawada S; Yonemura A; Iwamoto N; Ogura M; Tanaka N; Nakaya K; Kusuhara M; Nakamura H; Ohsuzu F
    Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):163-8. PubMed ID: 16254209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholesterol secretion and homeostasis in chondrocytes: a liver X receptor and retinoid X receptor heterodimer mediates apolipoprotein A1 expression.
    Gentili C; Tutolo G; Pianezzi A; Cancedda R; Descalzi Cancedda F
    Matrix Biol; 2005 Feb; 24(1):35-44. PubMed ID: 15749000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-Acylthiadiazolines, a new class of liver X receptor agonists with selectivity for LXRbeta.
    Molteni V; Li X; Nabakka J; Liang F; Wityak J; Koder A; Vargas L; Romeo R; Mitro N; Mak PA; Seidel HM; Haslam JA; Chow D; Tuntland T; Spalding TA; Brock A; Bradley M; Castrillo A; Tontonoz P; Saez E
    J Med Chem; 2007 Aug; 50(17):4255-9. PubMed ID: 17665897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of liver x receptor/retinoid X receptor-mediated transcription contributes to the proatherogenic effects of arsenic in macrophages in vitro.
    Padovani AM; Molina MF; Mann KK
    Arterioscler Thromb Vasc Biol; 2010 Jun; 30(6):1228-36. PubMed ID: 20339114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety, pharmacokinetics, and pharmacodynamics of single doses of LXR-623, a novel liver X-receptor agonist, in healthy participants.
    Katz A; Udata C; Ott E; Hickey L; Burczynski ME; Burghart P; Vesterqvist O; Meng X
    J Clin Pharmacol; 2009 Jun; 49(6):643-9. PubMed ID: 19398602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.